Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Materials and methods Study design and data sources This cross-sectional study analyzed publicly available data from three sources: ClinicalTrials.gov for GLP-1 receptor agonist trial eligibility criteria, the US National Health and Nutrition Examination Survey (NHANES) 20212023, and the Korea National Health and Nutrition Examination Survey (KNHANES) 20212023
The primary metric used was the percentage change from baseline latency, calculated as: [(post-drug latency pre-drug latency) / pre-drug latency] 100
New loci in lymphomagenesis identified by comparative genomic hybridization (CGH)
Duan L, An X, Zhang Y, et al
Neutralizes Free Radicals: Acting as a potent antioxidant, it helps combat oxidative stress and protects your skin from damage caused by free radicals
